Advance Science & Medicine by Connecting Patients to Life-Saving Therapeutics

📨 Email [email protected] to apply

Advance Science & Medicine by Connecting Patients to Life-Saving Therapeutics

<aside> 💡

Why Double Blind Bio (DBB)?

We Accelerate the Development of Next Generation Medicines

• We work directly with Clinical Research Sites, Sponsors and Clinical Research Organizations (CROs) to embed our technology to accelerate clinical trials.

We move fast

• We went from initial idea to product in customer’s hands in three weeks. In our first six months, we onboarded 200 research sites, landed our first pharma design partner and our existing lead investors SignalFire (Uber, Grammarly, Lime, Ro, Aura) and Define Ventures (hims & hers, Story Health) doubled down on their investment in us.

Work with Life Sciences Experts

• We have spent our careers working at the intersection of Life Sciences/Healthcare, Data and AI on both business development and technology. </aside>

You are the first dedicated seller on our site business, and you own how DBB wins clinical research sites, from the cold first touch through a signed pilot into a paying customer.

You build the motion while you run it.

WHAT DBB DOES

We build AI agents that take the operational load off clinical trials, so research teams spend their time on patients and science.

We sell to two buyers.

• Research sites pay a monthly subscription for our growth module, and we are live across 300+ of them.
• Pharma sponsors pay per trial for an embedded engagement where our agents and team work alongside their trial operations.

We are backed by Define Ventures, SignalFire, and Peterson Ventures, and the team comes from leading tech and life science companies.

WHAT YOU OWN

You land sites.

Self-sourcing the pipeline is the heart of the job.

You write and run your own outbound, create content,  you show up at sites in person, and you own the conference calendar end to end, picking the events, booking meetings before you land, and running the follow-up until it converts.

Once a site is interested you run discovery, stand up a pilot, and drive that pilot to paid.

Converting matters as much as opening, because the whole thesis rests on density that compounds.

The lines around the job are clear.

Once a site is paying, our customer success lead takes the account and you go land the next one.